Public annual accounts

EUROPEAN SOCIETY FOR RADIOTHERAPY AND ONCOLOGY financials

Name: EUROPEAN SOCIETY FOR RADIOTHERAPY AND ONCOLOGY financials
Creator: Upswitch
License: https://www.upswitch.app/terms-and-conditions

A multi-period view of the public annual-account figures reported for EUROPEAN SOCIETY FOR RADIOTHERAPY AND ONCOLOGY, with comparable measures and links to available source documents.

Company overview

Registry number

0432894370

Fiscal coverage

2024–2025

Public sources

cbso_bulk

Data updated

Jul 27, 2026

Financial evidence

Latest movements for EUROPEAN SOCIETY FOR RADIOTHERAPY AND ONCOLOGY

2025 versus 2024

Operating line: €3,652,955
EBITDA: €649,906
Total assets: €10,058,580
Equity: €4,123,975

EBITDA margin +17.8% · Equity ratio +41%

Multi-year filings

Filed annual accounts by fiscal year

Public regulator-filed figures across 2 years.

Source: NBB/CBSO

Fiscal year	Gross margin	EBITDA	Total assets	Equity	Filing
202531 Dec 2025	€3,652,955	€649,906	€10,058,580	€4,123,975	-
202431 Dec 2024	€3,716,653	€910,554	€9,032,570	€3,888,920	-

Gross margin line from gross margin (abbreviated schema). This is not reported turnover, so it is not used as a public valuation base.EBITDA basis: operating profit plus full add-backs.

Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.

Public company datasets

Explore the underlying reports

Valuation

2 valuation checkpoints · 2024 to 2025 · Method family

Open report

Fiscal year

Gross margin

EBITDA

Total assets

Equity

Filing

202531 Dec 2025

€3,652,955

€649,906

€10,058,580

€4,123,975

202431 Dec 2024

€3,716,653

€910,554

€9,032,570

€3,888,920